English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/213952
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:


Peptide therapeutics 2.0

Authorsde la Torre, Beatriz G.; Albericio, Fernando
KeywordsDrug discovery
Pharmaceutical Preparations
Issue DateApr-2020
PublisherMultidisciplinary Digital Publishing Institute
CitationMolecules 25 (10): 2293 (2020)
AbstractIn recent years, the peptide drug discovery field has shown a high level of dynamism, with hundreds of academic groups working on this topic, the creation of new peptide-focused companies, and the consolidation of peptide business by so-called big pharma
Publisher version (URL)https://doi.org/10.3390/molecules25102293
Appears in Collections:(IQAC) Artículos
Files in This Item:
File Description SizeFormat 
molecules-25-02293.pdfArtículo principal167,72 kBAdobe PDFThumbnail
Show full item record
Review this work

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.